Note: Ingredients listed on restricted chemical lists
EC/CAS
77-92-9
Name of the chemical
Citric acid
Concentration
N/A
EC/CAS
69-65-8
Name of the chemical
D-mannitol C6H14O6
Concentration
N/A
EC/CAS
128-44-9
Name of the chemical
1,2-benzisothiazol-3(2H)-one 1,1-dioxide, sodium salt
Concentration
N/A
EC/CAS
200-711-8
Name of the chemical
D-mannitol C6H14O6
Concentration
N/A
General Information
Revision date
2006-11-08
Product name
Mucoporetta
Chemical name
Not determined
Emergency telephone
(24 hours) 1-800-262-8200
Icons in SDS
Company Information
company name
Pfizer Inc
GHS Information
Signal word
None
Section 2
SECTION 2: Hazards identification
Appearance: Tablet
Signal word
None required
Hazard statements
Non-hazardous in accordance with international standards for workplace safety. Eye Contact: May cause eye irritation (based on components) Skin Contact: May cause skin irritation (based on components). Ingestion: Not acutely toxic (based on components) Known Clinical Effects: Adverse effects seen in clinical use include gastrointestinal discomfort, dizziness, and headache. Clinical use has caused symptoms of asthma.
Potential health effects
Individuals sensitive to this material or other materials in its chemical class may develop allergic reactions. EU Indication of danger: Not classified
Additional information
For a more detailed discussion of potential health hazards and toxicity see Section 11. Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
